DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Idea Award
Defense Health Agency Contracting Activity - DHACA · Opportunity HT942526ALSRPTIA
≈ 12 awards expected
Who can apply
- Unrestricted
About this opportunity
Summary: The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Therapeutic Idea Award (TIA) supports new, innovative, high-risk, high-gain ideas aimed at amyotrophic lateral sclerosis (ALS) drug or therapy discovery. The studies supported by this award mechanism are expected to be hypothesis-driven and generate preliminary data for future avenues of therapeutic investigation.Distinctive Features: Potential impact and innovation are important features of the TIA. Applications may demonstrate the ability to achieve interpretable results in the absence of preliminary data supporting the hypothesis. While the inclusion of preliminary data is not prohibited, the strength of the application should rely on the approach.
Similar grants still open
| Opportunity | Agency | Deadline | Award ceiling | Eligible |
|---|---|---|---|---|
| Small Business Innovation Research / Small Business Technology Transfer Phase I, Phase II, Fast-Track Programs (SBIR/STTR): A Pilot Emphasis on Scientific Instrumentation. | U.S. National Science Foundation | July 27, 2026 1d left | — | |
| Integrated Data Systems & Services | U.S. National Science Foundation | July 28, 2026 2d left | $30M | |
| DoW Kidney Cancer, Concept Award | Defense Health Agency Contracting Activity - DHACA | July 28, 2026 2d left | — | Nonprofits Individuals |
| Disability and Rehabilitation Research Projects (DRRP) Program: Model Systems Knowledge Translation Center | Administration for Community Living | July 29, 2026 3d left | $850k | Nonprofits |